Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9LQ3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,623
Award facts
- Contract value 100% obligated
- $36,622.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $36,622.95 delivery order to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 16, 2026, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by January 20, 2026. The place of performance is Conshohocken, Pennsylvania, which serves as Amerisourcebergen's corporate headquarters. This delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which functions as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Amerisourcebergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and U.S. Coast Guard. The company's extensive contract portfolio demonstrates its capability to supply diverse pharmaceutical products across multiple therapeutic domains on a competitive basis. The Eliquis delivery order represents a routine pharmaceutical supply transaction consistent with DLA's ongoing efforts to maintain adequate medication inventories for federal healthcare operations. As a major healthcare solutions provider, Cencora, Inc. also maintains a separate $999,999,999.00 IDC with DLA Troop Support Medical extending through December 2031, reinforcing the company's role as a primary supplier of essential medical commodities to military treatment facilities and federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F9LQ3?
SPE2DR26F9LQ3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9LQ3 worth?
The government has obligated $36,623 on SPE2DR26F9LQ3.
Is contract SPE2DR26F9LQ3 an order under another contract?
Yes. SPE2DR26F9LQ3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LQ3 competed?
The extent of competition for SPE2DR26F9LQ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award